DOCSLIB.ORG

Impaired Mitochondrial Fatty Acid Synthesis Leads to Neurodegeneration in Mice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Impaired Mitochondrial Fatty Acid Synthesis Leads to Neurodegeneration in Mice This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. Research Articles: Neurobiology of Disease Impaired mitochondrial fatty acid synthesis leads to neurodegeneration in mice Remya R. Nair1, Henna Koivisto2, Kimmo Jokivarsi2, Ilkka J. Miinalainen3, Kaija J. Autio1, Aki Manninen1,4, Heikki Tanila2, J. Kalervo Hiltunen1 and Alexander J. Kastaniotis1 1Faculty of Biochemistry and Molecular Medicine, University of Oulu, FI-90014 Oulu, Finland 2A. I. Virtanen Institute, University of Eastern Finland, FI-70211 Kuopio, Finland 3Electron Microscopy Core Facility, Biocenter Oulu, University of Oulu, FI-90014 Oulu, Finland 4Virus Core Facility, Biocenter Oulu, University of Oulu, FI-90014 Oulu, Finland DOI: 10.1523/JNEUROSCI.3514-17.2018 Received: 13 December 2017 Revised: 31 August 2018 Accepted: 19 September 2018 Published: 28 September 2018 Author contributions: R.R.N., A.M., H.T., J.K.H., and A.J.K. designed research; R.R.N., H.K., K.J., I.M., K.J.A., H.T., and J.K.H. performed research; R.R.N., H.K., K.J., I.M., K.J.A., A.M., H.T., J.K.H., and A.J.K. analyzed data; R.R.N., H.K., K.J., I.M., K.J.A., A.M., H.T., J.K.H., and A.J.K. wrote the paper; A.M. contributed unpublished reagents/analytic tools. Conflict of Interest: The authors declare no competing financial interests. We are grateful to Dr Raija Soininen for the continuous support at various stages of this project and critical review of this manuscript. The Biocenter Oulu Transgenic Core facility, the Biocenter Oulu EM laboratory and the Biocenter Oulu Virus Core laboratory, which are all part of Biocenter Finland, are acknowledged for the support in generating mice, in the EM analysis and the lentivirus production, respectively. We thank Juha M. Kerätär for providing Mecrtm1c strain for the project. We thank Leena Ollitervo, Anna Sofia Kuusisto, Miriam Martens, Jessica Müller and Belen Sintes Garcia for technical help with histology samples and Anna von Schaewen and Ujjwal Suwal for their work on the quantitation of fluorescence image data. We are grateful to Dr. Randy Woltjer (Oregon Health and Science University) for the reviewing in H&E stained cerebellar sections. The project was funded by the Academy of Finland, the Sigrid Jusélius Foundation, Finnish Cultural Foundation and Biocenter Finland. Correspondence should be addressed to To whom correspondence should be addressed: Faculty of Biochemistry and Molecular Medicine, University of Oulu, P.O. Box 5400, FI-90014 Oulu, Finland; Tel. +358294481196; email address: [email protected] Cite as: J. Neurosci ; 10.1523/JNEUROSCI.3514-17.2018 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published. Accepted manuscripts are peer-reviewed but have not been through the copyediting, formatting, or proofreading process. Copyright © 2018 the authors 1 Impaired mitochondrial fatty acid synthesis leads to neurodegeneration in mice 2 MECR and neurodegeneration 3 Remya R. Nair1#, Henna Koivisto2, Kimmo Jokivarsi2, Ilkka J. Miinalainen3, Kaija J. Autio1, Aki 4 Manninen1,4, Heikki Tanila2, J. Kalervo Hiltunen1 & Alexander J. Kastaniotis1* 5 1 Faculty of Biochemistry and Molecular Medicine, University of Oulu, FI-90014 Oulu, Finland; 6 2A. I. Virtanen Institute, University of Eastern Finland, FI-70211 Kuopio, Finland; 3Electron 7 Microscopy Core Facility, Biocenter Oulu, University of Oulu, FI-90014 Oulu, Finland; 4Virus 8 Core Facility, Biocenter Oulu, University of Oulu, FI-90014 Oulu, Finland 9 # Current address: MRC Harwell Institute, Harwell Science and Innovation campus, Didcot, 10 Oxfordshire OX11 0QG, United Kingdom. 11 12 *To whom correspondence should be addressed: Faculty of Biochemistry and Molecular Medicine, 13 University of Oulu, P.O. Box 5400, FI-90014 Oulu, Finland; Tel. +358294481196; email address: 14 [email protected] 15 16 Number of Pages: 45 17 Number of Figures: 15 18 Number of Tables: 3 19 Number of Words: 20 Abstract 229 21 Significance statement 112 22 Introduction 481 23 Discussion: 1497 24 The authors declare no competing financial interests. 1 25 Acknowledgements 26 We are grateful to Dr Raija Soininen for the continuous support at various stages of this project and 27 critical review of this manuscript. The Biocenter Oulu Transgenic Core facility, the Biocenter Oulu 28 EM laboratory and the Biocenter Oulu Virus Core laboratory, which are all part of Biocenter 29 Finland, are acknowledged for the support in generating mice, in the EM analysis and the lentivirus 30 production, respectively. We thank Juha M. Kerätär for providing Mecrtm1c strain for the project. 31 We thank Leena Ollitervo, Anna Sofia Kuusisto, Miriam Martens, Jessica Müller and Belen Sintes 32 Garcia for technical help with histology samples and Anna von Schaewen and Ujjwal Suwal for 33 their work on the quantitation of fluorescence image data. We are grateful to Dr. Randy Woltjer 34 (Oregon Health and Science University) for the reviewing in H&E stained cerebellar sections. The 35 project was funded by the Academy of Finland, the Sigrid Jusélius Foundation, Finnish Cultural 36 Foundation and Biocenter Finland. 37 38 2 39 Abstract 40 There has been a growing interest towards mitochondrial fatty acid synthesis (mtFAS) since the 41 recent discovery of a neurodegenerative human disorder termed MEPAN (mitochondrial enoyl 42 reductase protein associated neurodegeneration), caused by mutations in the mitochondrial enoyl- 43 CoA/ACP (acyl carrier protein) reductase (MECR) carrying out the last step of mtFAS. We show 44 here that MECR protein is highly expressed in mouse Purkinje cells (PCs). To elucidate mtFAS 45 function in neural tissue, we here generated a mouse line with a PC-specific knock-out (KO) of 46 Mecr, leading to inactivation of mtFAS confined to this cell type. Both sexes were studied. The 47 mitochondria in KO PCs displayed abnormal morphology, loss of protein lipoylation and reduced 48 respiratory chain enzymatic activities by the time these mice were 6 months of age, followed by 49 nearly complete loss of PCs by 9 months of age. These animals exhibited balancing difficulties 50 around 7 months of age and ataxic symptoms were evident from 8-9 months of age onwards. Our 51 data shows that impairment of mtFAS results in functional and ultrastructural changes in 52 mitochondria followed by death of PCs, mimicking aspects of the clinical phenotype. This KO 53 mouse represents a new model for impaired mitochondrial lipid metabolism and cerebellar ataxia 54 with a distinct and well-trackable cellular phenotype. This mouse model will allow the future 55 investigation of the feasibility of metabolite supplementation approaches towards the prevention of 56 neurodegeneration due to dysfunctional mtFAS. 57 58 3 59 Significance statement 60 We have recently reported a novel neurodegenerative disorder in humans termed MEPAN 61 (mitochondrial enoyl reductase protein associated neurodegeneration) (Heimer et al. 2016). The 62 cause of neuron degeneration in MEPAN patients is the dysfunction of the highly conserved 63 mitochondrial fatty acid synthesis (mtFAS) pathway due to mutations in MECR, encoding 64 mitochondrial 2-enoyl-ACP reductase. 65 The report presented here describes the analysis of the first mouse model suffering from mtFAS- 66 defect-induced neurodegenerative changes due to specific disruption of the Mecr gene in PCs. Our 67 work sheds a light on the mechanisms of neurodegeneration caused by mtFAS deficiency and 68 provides a test bed for future treatment approaches. 69 70 4 71 Introduction 72 Mitochondria are essential multipurpose organelles of intermediate and energy metabolism. 73 Especially the function of organs with high energy demands such as brain depends on flawless 74 mitochondrial operation for their optimal performance. Mitochondrial defects have been reported as 75 a cause for many neurodegenerative diseases (Johri and Beal, 2012), e.g. Alzheimer’s disease 76 (Moreira et al., 2010), Parkinson’s disease (Winklhofer and Haass, 2010), Huntington‘s disease 77 (Quintanilla and Johnson, 2009), Friedreich ataxia (Delatycki et al., 2000), as well as other 78 spinocerebellar ataxias (Zeviani et al., 2012). 79 As a reflection of the prokaryotic ancestry of the endosymbiotic organelle, mitochondria harbor a 80 fatty acid synthesis (mtFAS) pathway that closely follows the prokaryotic model, where each step 81 in the process is carried out by separate polypeptides. The enzymes in mammals involved with this 82 pathway have been identified (Hiltunen et al., 2010; Monteuuis et al., 2017). Octanoic acid is a 83 confirmed product of mtFAS and required as a precursor for endogenous synthesis of lipoic acid 84 (LA). In Saccharomyces cerevisiae, the inactivation of any of the enzymes of mtFAS leads to 85 respiratory defects, lack of cytochromes due to disturbed mitochondrial translation and respiratory 86 complex assembly, rudimentary mitochondria and loss of protein lipoylation (Kastaniotis et al., 87 2004; Hiltunen et al., 2009; Kursu et al., 2013). Evidence generated in yeast and mammalian 88 models indicates that, in addition to providing the LA precursor, mtFAS products play important 89 roles in mitochondrial biogenesis, affecting heme biosynthesis, regulating respiratory chain 90 assembly (Kursu et al. 2013, Zhu et al., 2017, Van Vranken et al. 2018) and participating in iron- 91 sulfur (Fe-S) cluster biosynthesis (Van Vranken et al., 2016, Cory et al., 2017). Two acylated acyl 92 carrier proteins (ACPs) of mtFAS, SDAP-α and SDAP-β, serve as structural components in the 93 mammalian complex I, (Caroll et al., 2013; Zhu et al., 2016). Acyl-ACPs have also been reported 94 to be required for the maturation of succinate dehydrogenase (Angerer et al., 2015). 5 95 MECR (mitochondrial enoyl-CoA reductase) catalyzes the NADPH-dependent reduction of enoyl 96 acyl carrier protein (ACP) to saturated acyl-ACP (Miinalainen et al., 2003). This is the last enzyme 97 of mtFAS pathway and essential for embryonic development in mouse (Nair et al., 2017).
Load more

Recommended publications
  • Proteomic and Metabolomic Analyses of Mitochondrial Complex I-Deficient
    THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 24, pp. 20652–20663, June 8, 2012 © 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Proteomic and Metabolomic Analyses of Mitochondrial Complex I-deficient Mouse Model Generated by Spontaneous B2 Short Interspersed Nuclear Element (SINE) Insertion into NADH Dehydrogenase (Ubiquinone) Fe-S Protein 4 (Ndufs4) Gene*□S Received for publication, November 25, 2011, and in revised form, April 5, 2012 Published, JBC Papers in Press, April 25, 2012, DOI 10.1074/jbc.M111.327601 Dillon W. Leong,a1 Jasper C. Komen,b1 Chelsee A. Hewitt,a Estelle Arnaud,c Matthew McKenzie,d Belinda Phipson,e Melanie Bahlo,e,f Adrienne Laskowski,b Sarah A. Kinkel,a,g,h Gayle M. Davey,g William R. Heath,g Anne K. Voss,a,h René P. Zahedi,i James J. Pitt,j Roman Chrast,c Albert Sickmann,i,k Michael T. Ryan,l Gordon K. Smyth,e,f,h b2 a,h,m,n3 David R. Thorburn, and Hamish S. Scott Downloaded from From the aMolecular Medicine Division, gImmunology Division, and eBioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia, the bMurdoch Childrens Research Institute, Royal Children’s Hospital and Department of Paediatrics, University of Melbourne, Parkville, Victoria 3052, Australia, the cDépartement de Génétique Médicale, Université de Lausanne, 1005 Lausanne, Switzerland, the dCentre for Reproduction and Development, Monash Institute of Medical Research, Clayton, Victoria 3168, Australia, the hDepartment of Medical Biology
    [Show full text]
  • Abstracts from the 50Th European Society of Human Genetics Conference: Electronic Posters
    European Journal of Human Genetics (2019) 26:820–1023 https://doi.org/10.1038/s41431-018-0248-6 ABSTRACT Abstracts from the 50th European Society of Human Genetics Conference: Electronic Posters Copenhagen, Denmark, May 27–30, 2017 Published online: 1 October 2018 © European Society of Human Genetics 2018 The ESHG 2017 marks the 50th Anniversary of the first ESHG Conference which took place in Copenhagen in 1967. Additional information about the event may be found on the conference website: https://2017.eshg.org/ Sponsorship: Publication of this supplement is sponsored by the European Society of Human Genetics. All authors were asked to address any potential bias in their abstract and to declare any competing financial interests. These disclosures are listed at the end of each abstract. Contributions of up to EUR 10 000 (ten thousand euros, or equivalent value in kind) per year per company are considered "modest". Contributions above EUR 10 000 per year are considered "significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal and fetal echocardiography. The molecular karyotyping Genetics revealed a gain in 8p11.22-p23.1 region with a size of 27.2 Mb containing 122 OMIM gene and a loss in 8p23.1- E-P01.02 p23.3 region with a size of 6.8 Mb containing 15 OMIM Prenatal diagnosis in a case of 8p inverted gene. The findings were correlated with 8p inverted dupli- duplication deletion syndrome cation deletion syndrome. Conclusion: Our study empha- sizes the importance of using additional molecular O¨. Kırbıyık, K. M. Erdog˘an, O¨.O¨zer Kaya, B. O¨zyılmaz, cytogenetic methods in clinical follow-up of complex Y.
    [Show full text]
  • Fatal Neonatal-Onset Mitochondrial Respiratory Chain Disease with T Cell Immunodeficiency
    0031-3998/06/6003-0321 PEDIATRIC RESEARCH Vol. 60, No. 3, 2006 Copyright © 2006 International Pediatric Research Foundation, Inc. Printed in U.S.A. Fatal Neonatal-Onset Mitochondrial Respiratory Chain Disease with T Cell Immunodeficiency JANINE REICHENBACH, RALF SCHUBERT, RITA HORVA` TH, JENS PETERSEN, NANCY FU¨ TTERER, ELISABETH MALLE, ANDREAS STUMPF, BORIS R. GEBHARDT, ULRIKE KOEHL, BURKHART SCHRAVEN, AND STEFAN ZIELEN Department of General Paediatrics [J.R., R.S., A.S., B.R.G., S.Z.], Department of Paediatric Haematology, Oncology and Haemostaselogy [U.K.], J.W. Goethe University Frankfurt, 60590 Frankfurt, Germany; Institutes of Clinical Chemistry, Molecular Diagnostics and Mitochondrial Genetics [R.H., E.M.], Academic Hospital Schwabing Munich, Children’s Hospital and Institute of Medical Genetics [N.F.], Technical University Munich, Metabolic Disease Center, Munich-Schwabing, 80804 Munich, Germany; Department of Neurology [J.P.], Friedrich-Baur-Institut, Ludwig-Maximilians-University Munich, 80336 Munich, Germany; Institute of Immunology [B.S.], Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany ABSTRACT: We present the clinical and laboratory features of a MDS is defined as a reduction of mtDNA copy number boy with a new syndrome of mitochondrial depletion syndrome and compared with nDNA in different tissues, which leads to T cell immunodeficiency. The child suffered from severe recurrent insufficient synthesis of RC complexes I, III, IV, and V (3). infectious diseases, anemia, and thrombocytopenia. Clinically, he Autosomal recessive mutations of five nuclear genes have presented with severe psychomotor retardation, axial hypotonia, and a disturbed pain perception leading to debilitating biting of the been identified in MDS patients with different clinical presen- thumb, lower lip, and tongue.
    [Show full text]
  • A High-Fat Diet Coordinately Downregulates Genes Required for Mitochondrial Oxidative Phosphorylation in Skeletal Muscle Lauren M
    A High-Fat Diet Coordinately Downregulates Genes Required for Mitochondrial Oxidative Phosphorylation in Skeletal Muscle Lauren M. Sparks, Hui Xie, Robert A. Koza, Randall Mynatt, Matthew W. Hulver, George A. Bray, and Steven R. Smith Obesity and type 2 diabetes have been associated with a ray studies have shown that genes involved in oxidative high-fat diet (HFD) and reduced mitochondrial mass phosphorylation (OXPHOS) exhibit reduced expression and function. We hypothesized a HFD may affect expres- levels in the skeletal muscle of type 2 diabetic subjects and sion of genes involved in mitochondrial function and prediabetic subjects. These changes may be mediated by biogenesis. To test this hypothesis, we fed 10 insulin- the peroxisome proliferator–activated receptor ␥ coacti- sensitive males an isoenergetic HFD for 3 days with vator-1 (PGC1) pathway. PGC1␣- and PGC1␤-responsive muscle biopsies before and after intervention. Oligonu- cleotide microarray analysis revealed 297 genes were OXPHOS genes show reduced expression in the muscle of differentially regulated by the HFD (Bonferonni ad- patients with type 2 diabetes (3,4). In addition to the justed P < 0.001). Six genes involved in oxidative cellular energy sensor AMP kinase, the peroxisome prolif- phosphorylation (OXPHOS) decreased. Four were mem- erator–activated receptor cofactors PGC1␣ (5–7) and pos- bers of mitochondrial complex I: NDUFB3, NDUFB5, sibly PGC1␤ (8) activate mitochondrial biogenesis and NDUFS1, and NDUFV1; one was SDHB in complex II and increase OXPHOS gene expression by increasing the tran- a mitochondrial carrier protein SLC25A12. Peroxisome scription, translation, and activation of the transcription proliferator–activated receptor ␥ coactivator-1 (PGC1) -and PGC1␤ mRNA were decreased by ؊20%, P < 0.01, factors necessary for mitochondrial DNA (mtDNA) repli ␣ and ؊25%, P < 0.01, respectively.
    [Show full text]
  • Anti-NDUFS1 Polyclonal Antibody Cat: K110186P Summary
    Anti-NDUFS1 Polyclonal Antibody Cat: K110186P Summary: 【Product name】: Anti-NDUFS1 Antibody 【Source】: Rabbit 【Isotype】: IgG 【Species reactivity】: Human Mouse Rat 【Swiss Prot】: P28331 【Gene ID】: 4719 【Calculated】: MW:68/73/75/79/81kDa 【Purification】: Octanoic acid-ammonium sulfate precipitation 【Tested applications】: IHC 【Recommended dilution】: IHC 1:50-200. 【IHC Positive sample】: Human breast cancer 【Subcellular location】: Cytoplasm 【Immunogen】: A synthetic peptide of human NDUFS1 【Storage】: Shipped at 4°C. Upon delivery aliquot and store at -20°C Background: The protein encoded by this gene belongs to the complex I 75 kDa subunit family. Mammalian complex I is composed of 45 different subunits. It locates at the mitochondrial inner membrane. This protein has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. This protein is the largest subunit of complex I and it is a component of the iron-sulfur (IP) fragment of the enzyme. It may form part of the active site crevice where NADH is oxidized. Mutations in this gene are associated with complex I deficiency. Several transcript variants encoding different isoforms have been found for this gene. Sales:[email protected] Tech:[email protected] For research purposes only. Tel:400-968-6088 Please visit www.solarbio.com for a more product information Verified picture Immunohistochemistry of paraffin-embedded Human breast cancer with NDUFS1 antibody diluted at 1:100 Sales:[email protected] Tech:[email protected] For research purposes only. Tel:400-968-6088 Please visit www.solarbio.com for a more product information.
    [Show full text]
  • Inositol Phosphate in the Basidiomycete Fungus Schizophyllum Commune
    Inositol phosphate in the basidiomycete fungus Schizophyllum commune Dissertation To fulfill the Requirements for the Degree of „doctor rerum naturalium“ (Dr. rer. nat.) Submitted to the Council of the Faculty of Biological Science of the Friedrich Schiller University Jena by Reyna Carmina Felicia Murry, MSc. born on the 22nd of October 1987 in Bandung, Indonesia First reviewer: Prof. Dr. Erika Kothe, Institut für Mikrobiologie, FSU Jena Second Reviewer: Prof. Dr. Axel A. Brakhage, Institut für Mikrobiologie, FSU Jena Third Reviewer: Prof. Dr. J. Stephen Horton, Department of Biological Sciences, Science and Engineering Center, Union College, Schenectady, New York, USA Date of public defense: 7th May 2019 “Science is the key to our future, and if you don't believe in science, then you're holding everybody back.” Bill Nye Table of Contents 1 Introduction ......................................................................................................................... 1 1.1 Schizophyllum commune .............................................................................................. 1 1.2 Fruiting body development in S. commune ................................................................. 3 1.3 Signal transduction: G-protein-coupled receptors (GPCRs) and Ras signaling .......... 4 1.4 Inositol-based metabolism and signaling: inositol phosphates and inositol lipids ...... 5 1.5 Inositol and inositol monophosphatase ........................................................................ 7 1.6 Inositol hexakisphosphate and
    [Show full text]
  • A Novel Mutation in NDUFS4 Causes Leigh Syndrome in an Ashkenazi Jewish Family
    J Inherit Metab Dis (2008) 31 (Suppl 2):S461–S467 DOI 10.1007/s10545-008-1049-9 SHORT REPORT A novel mutation in NDUFS4 causes Leigh syndrome in an Ashkenazi Jewish family S. L. Anderson & W. K. Chung & J. Frezzo & J. C. Papp & J. Ekstein & S. DiMauro & B. Y. Rubin Received: 15 September 2008 /Submitted in revised form: 13 November 2008 /Accepted: 19 November 2008 / Published online: 26 December 2008 # SSIEM and Springer 2008 Summary Leigh syndrome is a neurodegenerative without consanguinity with three affected children. disorder of infancy or childhood generally due to Linkage to microsatellite markers D5S1969 and mutations in nuclear or mitochondrial genes involved D5S407 led to evaluation of the complex I gene in mitochondrial energy metabolism. We performed NDUFS4, in which we identified a novel homozygous linkage analysis in an Ashkenazi Jewish (AJ) family c.462delA mutation that disrupts the reading frame. The resulting protein lacks a cAMP-dependent protein kinase phosphorylation site required for activation of Communicating editor: John Christodoulou mitochondrial respiratory chain complex I. In a Competing interests: None declared random sample of 5000 healthy AJ individuals, the References to electronic databases: Leigh syndrome: OMIM carrier frequency of the NDUFS4 mutation c.462delA 256000. NDUFS4: OMIM 602694. NDUFS4 mRNA: GenBank was 1 in 1000, suggesting that it should be considered accession # NM_002495. : : in all AJ patients with Leigh syndrome. S. L. Anderson J. Frezzo B. Y. Rubin (*) Department of Biological Sciences, Fordham University, Abbreviations 441 E. Fordham Rd., Bronx, NY 10458, USA AJ Ashkenazi Jewish e-mail: [email protected] BCS1L BCS1-like protein W.
    [Show full text]
  • Supplementary Table S1. Relative Change in Proteins Associated with Heme Biosynthesis and Degradation
    Supplementary Table S1. Relative change in proteins associated with heme biosynthesis and degradation. hPXR mPxr–/– Protein Gene RIF/INH INH RIF RIF/INH p Value 5-aminolevulinate synthase Alas1 1.90 2.61 1.05 1.41 0.28 5-aminolevulinate synthase Alas2 0.86 1.38 0.73 1.18 0.018 Delta-aminolevulinic acid Alad 0.96 1.00 1.02 0.95 0.75 dehydratase Porphobilinogen deaminase Hmbs 1.04 0.99 1.10 1.05 0.67 Uroporphyrinogen-III synthase Uros 1.19 1.09 1.31 1.38 0.012 Uroporphyrinogen decarboxylase Urod 0.92 1.03 0.94 0.92 0.33 Oxygen-dependent Cpox 1.13 1.04 1.18 1.15 0.20 coproporphyrinogen-III oxidase, Protoporphyrinogen oxidase Ppox 0.69 0.81 0.85 0.83 0.013 Ferrochelatase, Fech 0.39 0.50 0.88 0.43 0.000002 Heme oxygenase 1 Hmox1 1.15 0.86 0.91 1.11 0.34 Heme oxygenase 2 Hmox2 0.96 0.98 0.89 0.88 0.22 Biliverdin reductase A Blvra 0.84 0.92 0.82 0.92 0.032 UDP-glucuronosyltransferase 1-6 Ugt1a6 1.22 0.96 1.10 1.13 0.30 NADPH--cytochrome P450 Por 1.28 0.92 1.18 1.12 0.019 reductase INH, isoniazid; RIF, rifampicin; RIF/INH, rifampicin and isoniazid. Supplementary Table S2. Relative change in protein nuclear receptors. hPXR mPxr–/– Protein Gene RIF/INH INH RIF RIF/INH p Value Aryl hydrocarbon receptor Ahr 1.09 0.91 1.00 1.26 0.092 Hepatocyte nuclear factor Hnf1a 0.87 0.97 0.82 0.79 0.027 1-alpha Hepatocyte nuclear factor Hnf4a 0.95 1.05 0.97 1.08 0.20 4-alpha Oxysterols receptor LXR- Nr1h3 0.94 1.16 1.03 1.02 0.42 alpha Bile acid receptor Nr1h4 1.05 1.17 0.98 1.19 0.12 Retinoic acid receptor Rxra 0.88 1.03 0.83 0.95 0.12 RXR-alpha Peroxisome proliferator-
    [Show full text]
  • Epigenetic Programming by Prenatal Stress in Female Serotonin Transporter Deficient Mice
    Epigenetic programming by prenatal stress in female serotonin transporter deficient mice Epigenetische Programmierung durch Pränatalstress in weiblichen Serotonintransporter-defizienten Mäusen Doctoral thesis for a doctoral degree at the Graduate School of Life Sciences, Julius-Maximilians-Universität Würzburg, Section Neuroscience Submitted by Karla-Gerlinde Schraut from Timişoara, România Würzburg, 2015 Submitted on: ............................................................................. Members of the Promotionskomitee: Chairperson: Prof. Dr. Thomas Dandekar Primary Supervisor: Prof. Dr. Klaus-Peter Lesch Supervisor (Second): Prof. Dr. Charlotte Förster Supervisor (Third): Dr. Daniel van den Hove Date of Public Defense: ............................................................... Date of Receipt of Certificates: .................................................... Table of Contents Table of Contents ................................................................................................................................ I Abbreviations ..................................................................................................................................... V Summary…………………………………………………………………………………………………..XI Zusammenfassung ........................................................................................................................... XV 1. General introduction ................................................................................................... 1 1.1. Variation in the serotonin transporter
    [Show full text]
  • Analysis of Human Mutations in the Supernumerary Subunits of Complex I
    life Review Analysis of Human Mutations in the Supernumerary Subunits of Complex I Quynh-Chi L. Dang, Duong H. Phan, Abigail N. Johnson, Mukund Pasapuleti, Hind A. Alkhaldi, Fang Zhang and Steven B. Vik * Department of Biological Sciences, Southern Methodist University, Dallas, TX 75287, USA; [email protected] (Q.-C.L.D.); [email protected] (D.H.P.); [email protected] (A.N.J.); [email protected] (M.P.); [email protected] (H.A.A.); [email protected] (F.Z.) * Correspondence: [email protected] Received: 30 October 2020; Accepted: 16 November 2020; Published: 20 November 2020 Abstract: Complex I is the largest member of the electron transport chain in human mitochondria. It comprises 45 subunits and requires at least 15 assembly factors. The subunits can be divided into 14 “core” subunits that carry out oxidation–reduction reactions and proton translocation, as well as 31 additional supernumerary (or accessory) subunits whose functions are less well known. Diminished levels of complex I activity are seen in many mitochondrial disease states. This review seeks to tabulate mutations in the supernumerary subunits of humans that appear to cause disease. Mutations in 20 of the supernumerary subunits have been identified. The mutations were analyzed in light of the tertiary and quaternary structure of human complex I (PDB id = 5xtd). Mutations were found that might disrupt the folding of that subunit or that would weaken binding to another subunit. In some cases, it appeared that no protein was made or, at least, could not be detected. A very common outcome is the lack of assembly of complex I when supernumerary subunits are mutated or missing.
    [Show full text]
  • PRAVEEN KUMAR DHANDAPANI: Expressing Alternative Oxidase
    PRAVEEN KUMAR DHANDAPANI DHANDAPANI KUMAR PRAVEEN DISSERTATIONES SCHOLAE DOCTORALIS AD SANITATEM INVESTIGANDAM EXPRESSING ALTERNATIVE OXIDASE (AOX) IN MICE: A VALUABLE TOOL TO STUDY MITOCHONDRIAL RESPIRATORY CHAIN DEFECTS RESPIRATORY MITOCHONDRIAL STUDY TO TOOL IN MICE: A VALUABLE (AOX) OXIDASE ALTERNATIVE EXPRESSING UNIVERSITATIS HELSINKIENSIS PRAVEEN KUMAR DHANDAPANI EXPRESSING ALTERNATIVE OXIDASE (AOX) IN MICE: A VALUABLE TOOL TO STUDY MITOCHONDRIAL RESPIRATORY CHAIN DEFECTS ISBN 978-951-51-5998-4 (PRINT) ISBN 978-951-51-5999-1 (ONLINE) ISSN 2342-3161 (PRINT) ISSN 2342-317X (ONLINE) http://ethesis.helsinki.fi HELSINKI 2020 FACULTY OF MEDICINE DOCTORAL PROGRAM IN BIOMEDICINE UNIVERSITY OF HELSINKI 32/2020 Doctoral Programme in Biomedicine Faculty of Medicine University of Helsinki Finland Expressing alternative oxidase (AOX) in mice: A valuable tool to study mitochondrial respiratory chain defects Praveen Kumar Dhandapani ACADEMIC DISSERTATION To be presented, with the permission of Faculty of Medicine of the University of Helsinki, for public examination in room P674, Porthania, Yliopistonkatu 3, Helsinki, on 05.06.2020, at noon. Helsinki 2020 Supervised by Marten Szibor, MD Prof. Howard T. Jacobs, PhD Clinic for Heart and Thorax Surgery Faculty of Medicine and Health Technology Jena University Hospital Tampere University Friedrich-Schiller University of Jena Thesis committee Prof. Katriina Aalto-Setälä, MD, PhD Prof. Klaus-Dieter Schlüter, PhD Faculty of Medicine and Health Physiological Institute Technology Faculty of Medicine Tampere University Justus-Liebig University of Giessen Reviewed by Jaakko Pohjoismäki, PhD Prof. Roberta A. Gottlieb, MD Department of Environmental and Department of Medicine; Department of Biological Sciences Biomedical Sciences University of Eastern Finland Smidt Heart Institute Cedars-Sinai Medical Center Opponent Prof.
    [Show full text]
  • Activation of the Endogenous Renin-Angiotensin- Aldosterone System Or Aldosterone Administration Increases Urinary Exosomal Sodium Channel Excretion
    CLINICAL RESEARCH www.jasn.org Activation of the Endogenous Renin-Angiotensin- Aldosterone System or Aldosterone Administration Increases Urinary Exosomal Sodium Channel Excretion † † Ying Qi,* Xiaojing Wang, Kristie L. Rose,* W. Hayes MacDonald,* Bing Zhang, ‡ | Kevin L. Schey,* and James M. Luther § Departments of *Biochemistry, †Bioinformatics, ‡Division of Clinical Pharmacology, Department of Medicine, §Division of Nephrology, Department of Medicine, and |Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee ABSTRACT Urinary exosomes secreted by multiple cell types in the kidney may participate in intercellular signaling and provide an enriched source of kidney-specific proteins for biomarker discovery. Factors that alter the exosomal protein content remain unknown. To determine whether endogenous and exogenous hormones modify urinary exosomal protein content, we analyzed samples from 14 mildly hypertensive patients in a crossover study during a high-sodium (HS, 160 mmol/d) diet and low-sodium (LS, 20 mmol/d) diet to activate the endogenous renin-angiotensin-aldosterone system. We further analyzed selected exosomal protein content in a separate cohort of healthy persons receiving intravenous aldosterone (0.7 mg/kg per hour for 10 hours) versus vehicle infusion. The LS diet increased plasma renin activity and aldosterone concentration, whereas aldosterone infusion increased only aldosterone concentration. Protein analysis of paired urine exosome samples by liquid chromatography-tandem mass spectrometry–based multidimen- sional protein identification technology detected 2775 unique proteins, of which 316 exhibited signifi- cantly altered abundance during LS diet. Sodium chloride cotransporter (NCC) and a-andg-epithelial sodium channel (ENaC) subunits from the discovery set were verified using targeted multiple reaction monitoring mass spectrometry quantified with isotope-labeled peptide standards.
    [Show full text]